Showing results (511-520 of 521) with videos related to
Sort By:
Pageof 53
Lancet (London, England)|December 7, 1996
Birthweight as a risk factor for breast cancerK B Michels, D Trichopoulos, J M Robins, et al.JAMA|October 7, 1997
A prospective study of pregravid determinants of gestational diabetes mellitusC G Solomon, W C Willett, V J Carey, et al.Journal of Medicinal Chemistry|July 18, 1997
2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivoM A Naylor, M Jaffar, J Nolan, et al.Carcinogenesis|December 12, 1997
A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancerD J Hunter, S E Hankinson, H Hough, et al.The British Journal of Cancer. Supplement|July 1, 1996
Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugsP Wardman, K I Priyadarsini, M F Dennis, et al.The New England Journal of Medicine|June 19, 1997
Postmenopausal hormone therapy and mortalityF Grodstein, M J Stampfer, G A Colditz, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 1999
Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinonesM Jaffar, S A Everett, M A Naylor, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident casesK T Kelsey, S E Hankinson, G A Colditz, et al.JAMA|April 27, 1999
A prospective study of egg consumption and risk of cardiovascular disease in men and womenF B Hu, M J Stampfer, E B Rimm, et al.Journal of Medicinal Chemistry|July 21, 1998
Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitroM A Naylor, E Swann, S A Everett, et al.Pageof 53